Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
The Journal of Allergy and Clinical Immunology
|
May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity
Emily S J Edwards, Julia Bier, Theresa S Cole, et al.
Journal of Clinical Immunology
|
June 21, 2020
Everolimus-Induced Remission of Classic Kaposi's Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency
Jin Yan Yap, Brian Gloss, Marcel Batten, et al.
Journal of Clinical Immunology
|
July 5, 2023
Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
Aleha Pillay, Avani Yeola, Fiona Tea, et al.
Nature Communications
|
July 12, 2019
Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia
Mingjing Hu, David Eviston, Peter Hsu, et al.
The Journal of Experimental Medicine
|
December 17, 2019
Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production
Anthony Lau, Danielle T Avery, Katherine Jackson, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cells
Julia Bier, Geetha Rao, Kathryn Payne, et al.
JCI Insight
|
April 26, 2019
Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients
Bethany A Pillay, Danielle T Avery, Joanne M Smart, et al.
The Journal of Experimental Medicine
|
July 19, 2018
Germline-activating mutations in <i>PIK3CD</i> compromise B cell development and function
Danielle T Avery, Alisa Kane, Tina Nguyen, et al.
Journal of Medicinal Chemistry
|
March 2, 2026
Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C
Matthew L Landry, Sushant Malhotra, Maureen Beresini, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State Inhibitors
Michael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
The Journal of Allergy and Clinical Immunology
|
May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity
Emily S J Edwards, Julia Bier, Theresa S Cole, et al.
Journal of Clinical Immunology
|
June 21, 2020
Everolimus-Induced Remission of Classic Kaposi's Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency
Jin Yan Yap, Brian Gloss, Marcel Batten, et al.
Journal of Clinical Immunology
|
July 5, 2023
Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
Aleha Pillay, Avani Yeola, Fiona Tea, et al.
Nature Communications
|
July 12, 2019
Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia
Mingjing Hu, David Eviston, Peter Hsu, et al.
The Journal of Experimental Medicine
|
December 17, 2019
Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production
Anthony Lau, Danielle T Avery, Katherine Jackson, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cells
Julia Bier, Geetha Rao, Kathryn Payne, et al.
JCI Insight
|
April 26, 2019
Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients
Bethany A Pillay, Danielle T Avery, Joanne M Smart, et al.
The Journal of Experimental Medicine
|
July 19, 2018
Germline-activating mutations in <i>PIK3CD</i> compromise B cell development and function
Danielle T Avery, Alisa Kane, Tina Nguyen, et al.
Journal of Medicinal Chemistry
|
March 2, 2026
Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C
Matthew L Landry, Sushant Malhotra, Maureen Beresini, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State Inhibitors
Michael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.
Page
of 7